(2R)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)NON-8-ENOIC ACID, 95.0%, 100mg

Dimethyldiselenide, 98.0%, 200mg

(S)-2-(4-(tert-Butyl)-4,5-dihydrooxazol-2-yl)propan-2-ol, 95.0%, 1g

(1R,5S)-3-Methyl-3,4,5,6-tetrahydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-8(2H)-one, 98%, 250mg

(2-Benzothiazolylthio)acetic Acid>98.0%(HPLC)(T)25g

1-Acetyl-4-piperidinecarboxylic Acid>98.0%(GC)(T)5g

(S)-1-(Pyridin-4-yl)ethanol, 95.0%, 1g

tert-Butyl 4-amino-2-(trifluoromethyl)benzoate, 95%, 5g

tert-butyl [cis-4-amino-1,1-dioxidotetrahydro-3-thienyl]carbamate, 95.0%, 250mg

Anti-Influenza A Virus Hemagglutinin H3 Monoclonal Antibody (Preservative : 0.05% NaN3, Stabilizer : 1% BSA)0.2mL

Reactors for Peptide Synthesis, 2 ml, 10 pieces, 10 pieces

Tablet pans flat shape, , 140 mm, Height, 25 mm, 1 Piece

Ethyl 2-(cyclobutylamino)-2-oxoacetate, 98%, 1g